Vagus Nerve Stimulation for Chronic Pain via Cholinergic Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pain treatment methods, especially for chronic pain, often fail to effectively manage neuropathic pain caused by glial cell dysfunction, leading to increased dosages and eventual ineffectiveness, as they do not adequately address the cytokine-mediated pain pathways.
Innovation Solution
The modulation of the cholinergic anti-inflammatory pathway through electrical stimulation of the vagus nerve, concurrent with spinal cord stimulation, to disrupt the release of inflammatory cytokines from glial cells, thereby enhancing the effectiveness of existing pain management therapies such as spinal cord stimulation, opioid therapies, and TENS.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional pain drugs are used to treat chronic pain, then pain relief is initially achieved, but dosages must be increased over time and eventual ineffectiveness occurs
Solution Approach 1:
The patent introduces electrical stimulation of the vagus nerve as an intermediary mechanism that modulates the cholinergic anti-inflammatory pathway. This intermediary action disrupts the release of inflammatory cytokines from glial cells, thereby enhancing pain relief effectiveness without requiring increased narcotic dosages. The vagus nerve stimulation serves as a mediator between the pain stimulus and the neural response, providing sustained pain management.
Solution Approach 2:
The patent changes the physiological parameter of cytokine release by utilizing electrical stimulation to modulate the cholinergic anti-inflammatory pathway. By altering the release parameters of inflammatory cytokines from glial cells, the system achieves enhanced pain relief effectiveness while maintaining stable narcotic dosage requirements, thus resolving the contradiction between reliability and quantity.
2Reliability
If spinal cord stimulation is used for pain management, then pain relief is achieved, but desensitization occurs over time
Solution Approach 1:
The patent implements continuous modulation of the cholinergic anti-inflammatory pathway through ongoing vagus nerve electrical stimulation. This continuous action prevents the desensitization that would otherwise occur with prolonged spinal cord stimulation alone. By maintaining sustained disruption of cytokine release, the system ensures continuous pain management effectiveness without the waning effect that leads to desensitization.
Solution Approach 2:
The vagus nerve stimulation acts as an intermediary that enhances and sustains the effects of spinal cord stimulation. This intermediary mechanism provides an additional layer of pain management that prevents desensitization by continuously modulating inflammatory cytokine release, thereby extending the duration of effectiveness.
3Reliability
If glial cell dysfunction is addressed, then neuropathic pain is reduced, but the complexity of treatment increases
Solution Approach 1:
The patent uses electrical stimulation of the vagus nerve as an intermediary approach to indirectly address glial cell dysfunction. Rather than directly targeting glial cells with complex interventions, the system uses vagus nerve stimulation as a mediator that disrupts cytokine release from glial cells, simplifying the treatment approach while effectively managing neuropathic pain.
Solution Approach 2:
The patent replaces complex direct interventions with electrical stimulation, a simpler and more manageable form of treatment. By substituting direct glial cell targeting with electrical modulation of the cholinergic pathway, the system reduces treatment complexity while maintaining effectiveness in managing neuropathic pain.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces the dosage and frequency of narcotic use, prevents desensitization, and provides long-term pain relief by modulating cytokine release, enhancing the efficacy of spinal cord stimulation and other pain management systems.
Implementation Method 1
The modulation of the cholinergic anti-inflammatory pathway through electrical stimulation of the vagus nerve
Data Source
AI summary
Methods and devices for the treatment of chronic pain by modulation of the cholinergic anti-inflammatory pathway. In particular, the methods and systems described herein may be used to enhance chronic pain therapies such as spinal cord stimulation (SCS). Thus, the present invention describes devices and methods for modulation of the cytokine pathway by stimulation of the neuronal cholinergic anti-inflammatory pathway (NCAP) to enhance the treatment of chronic pain by SCS. The use of NCAP in conjunction with SCS may potentiate the effects of SCS and/or prevent the desensitization of the patient to SCS.